Payers and pharma in SA are still unable to work collaboratively to decide how drugs are paid for – causing difficulties for pharma to provide patients with essential medicines.
eyeforpharma recently spoke with Dr João Carapinha, Chief Market Access Scientist at Carapinha & Consultants on how this could soon change. João discusses how offering rebates will boost competition and increase patient access to essential drugs. He also explores why pharma must work closer with payers to fully understand reimbursement criteria and increase funding for their products.
Click here to read the full interview.
